{ event: "article_read", name: `A Discussion on Hospital-associated VTE: Keeping the Monster at Bay`, author: ``, tags: `Thrombosis`, publication_date: ``, interaction_type: "content" }
A Discussion on Hospital-associated VTE: Keeping the Monster at Bay
This webinar was a scientific discussion on venous thromboembolism (VTE) management in which experts like Dr. Ravindra Mehta (MD), Prof. Beverley Jane Hunt (OBE, FRCP, FRCPath, MD) and Dr. Khusrav Bajan (MD, EDIC, FICCM, FICP) shared their views and insights concerning the risk reduction of hospital-associated VTE.
The context of this discussion disclosed the view on the global burden and consequences of the disease, where the prevalence was looked at both within the hospital, ICU vs. non-ICU patients, in hospitalised vs. non-hospitalised patients, as well as the risk factors of VTE in hospital patients and the challenges faced during VTE management in this population. The underutilisation of thromboprophylaxis and its impact on the treatment strategies based on various VTE risk assessment models were some of the key highlights. Additionally, in this segment, examples via case studies, along with clinical data and guideline recommendations, were comprised as the supporting growing body of data.
You are now being redirected to a third-party website.
Sanofi does not endorse or approve the content, products, services or opinions on the third-party website. Sanofi shall not be responsible or in any way liable for any injury or damage to any persons in view of any reliance placed on or action taken basis of the information on the third party website or any errors, omissions or inaccuracies and/or incompleteness of the information on the third party website.
Right answer: Both A and B. As per Diabetic & Ramadan guidelines, T2DM patients can safely continue glargine U-100 once daily at a reduced dose of 15 - 30% at Iftar1,2. Insulin glargine U-100 is safe to be used during Ramadan with no significant increase in hypoglycaemia3. One-on-one dietary educational session can also reduce the number of adverse events of fasting1.
